Swiss (SMI) Growth Pharmaceuticals & Biotech Stocks

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
PPGN PolyPeptide Group	CHF 28.40	-0.7%	59.6%	CHF 936.7m	CHF 36.25	PS3.1x	E64.2%	0%
NWRN Newron Pharmaceuticals	CHF 8.95	5.4%	45.8%	CHF 174.2m	CHF 14.39	PS26.6x	E45.9%	n/a
GALD Galderma Group	CHF 100.64	2.3%	n/a	CHF 23.9b	CHF 99.88	PS6.1x	E36.4%	n/a
SANN Santhera Pharmaceuticals Holding	CHF 13.82	20.8%	47.8%	CHF 167.3m	CHF 32.00	PE2.7x	E30.3%	n/a
SDZ Sandoz Group	CHF 37.17	0.3%	29.5%	CHF 16.3b	CHF 43.50	PS1.8x	E29.9%	1.2%
COPN Cosmo Pharmaceuticals	CHF 63.70	4.1%	13.3%	CHF 1.0b	CHF 97.30	PE15.6x	E21.5%	2.9%
LONN Lonza Group	CHF 535.80	0.6%	52.8%	CHF 38.7b	CHF 636.90	PE67.5x	E21.2%	0.7%
BANB Bachem Holding	CHF 57.90	0.2%	-5.9%	CHF 4.3b	CHF 83.57	PE38.2x	E17.9%	1.4%
SKAN SKAN Group	CHF 76.20	-0.3%	-3.8%	CHF 1.7b	CHF 90.67	PE53.1x	E17.8%	0.5%
IDIA Idorsia	CHF 0.82	12.6%	-60.7%	CHF 154.8m	CHF 1.00	PS2.1x	E17.4%	n/a
BSLN Basilea Pharmaceutica	CHF 41.35	0.5%	19.9%	CHF 501.2m	CHF 77.25	PS3.4x	E14.9%	0%
TECN Tecan Group	CHF 202.60	-0.2%	-37.6%	CHF 2.6b	CHF 284.86	PE25.6x	E14.8%	1.5%
SFZN Siegfried Holding	CHF 986.00	0.7%	17.2%	CHF 4.2b	CHF 1,187.67	PE32.8x	E13.0%	0.4%
ROG Roche Holding	CHF 255.50	1.8%	0.5%	CHF 205.2b	CHF 303.36	PE19.2x	E10.5%	3.8%
MOLN Molecular Partners	CHF 4.06	-12.3%	7.4%	CHF 149.7m	CHF 9.75	PS24.9x	E10.2%	n/a
NOVN Novartis	CHF 88.70	1.2%	-1.3%	CHF 177.3b	CHF 104.40	PE16.6x	E7.1%	3.7%
ADXN Addex Therapeutics	CHF 0.057	-1.0%	16.7%	CHF 5.6m	n/a	PS9.5x	E0.6%	n/a
ACHI Achiko	CHF 0.0004	0%	-98.9%	CHF 58.1k	n/a	PS2.6x	n/a	n/a
OBSN ObsEva	CHF 0.0012	0%	-98.2%	CHF 140.6k	n/a	PE0.02x	n/a	n/a
KNRS Kinarus Therapeutics Holding	CHF 16.13	5.9%	-66.7%	CHF 3.9m	n/a	n/a	n/a	n/a
RLF Relief Therapeutics Holding	CHF 4.21	2.7%	128.8%	CHF 52.8m	n/a	PS6.1x	n/a	n/a
SPEX Spexis	CHF 0.065	0%	62.5%	CHF 4.4m	n/a	PS7.4x	n/a	n/a
KURN Kuros Biosciences	CHF 21.35	5.7%	355.2%	CHF 802.2m	n/a	PS15.3x	n/a	n/a
DESN Dottikon ES Holding	CHF 221.00	2.1%	0.2%	CHF 3.1b	CHF 350.00	PE40.4x	S16.4%	0%